Articles

Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicentre, open-label phase-II trial

University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Würzburg, Medical Center, Medical Clinic II, Würzburg, Germany;
Tagesklinik Landshut, Landshut, Germany;
University Hospital Essen, Department for Hematology, West German Cancer Center, Essen, Germany;
Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany;
Mannheimer Onkologie Praxis, Mannheim, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
Department III of Internal Medicine, Rostock University Medical Center, Rostock, Germany;
Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany;
Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany;
Department of Hematology, Oncology, Immunology, Klinikum Schwabing, Munich, Germany
Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
University of Cologne, Dept. of Internal Medic University Hospital of Cologne, Germany;
Haematologica Early view Feb 27, 2020 https://doi.org/10.3324/haematol.2019.223693